(Q45112898)

English

Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD).

scientific article published in January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD). (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

J C Grutters

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

A R Hermus

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

P H de Mulder

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

L V Beex

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

277-281

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP

1 reference

https://pubmed.ncbi.nlm.nih.gov/8369528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8369528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8369528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8369528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8369528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00689842

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45112898&oldid=2207103846"